Clinical Trial Update: Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an autologous neo-bladder construct for non-neurogenic overactive bladder with urge incontinence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Snippet

Sponsor: Tengion | Conditions: Overactive Bladder | Phase 2 | Status: WITHDRAWN